Medium Risk

Anupam Rasayan India Limited

Manufacturing of Intermediate Specialty chemical and chemical products pharmaceuticals medicinal chemical and botanical

CIN: L24231GJ2003PLC042988 FY: - Revenue: ₹1,437.0 Cr
5.2
ESG Risk
Score /10
Compliance RiskGhg IntensityWater Intensity

Risk Breakdown

GHG Intensity
5.0
Water Intensity
5.0
Waste Intensity
2.9
EPR Exposure
5.0
Compliance Risk
10.0
HR Risk
3.0
Governance Risk
3.0

Financial Exposure

Est. Compliance Cost₹2–9 crore
EPR ApplicableUnknown
Scope 1 Emissions— tCO2e
Scope 2 Emissions— tCO2e
Water Withdrawal— m³
Waste Generated30,489.0 T

Governance

Anti-Corruption PolicyYes
Conflict of Interest PolicyYes
BRSR AssurancePartial
Assurance ProviderTUV SUD SOUTH ASIA PVT LTD

Double Materiality

Financial Materiality5.2
Impact Materiality4.9
QuadrantFinancially Material

Supply Chain

MSME Sourcing0.0%
Lifecycle AssessmentYes
Product ReclaimYes

Material Risks

e-waste

ESG Targets & Commitments

TopicTarget / MetricStatus
Life Cycle Assessment LCA conducted for products Achieved
Human Rights in Supply Chain HR clauses in all contracts Commitment

AI Risk Summary

**Financial Risk Summary – Anupam Rasayan India Limited** Anupam Rasayan faces its largest financial exposure through compliance risk (10.0/10 score), with estimated remediation costs of ₹2–9 crore annually, driven by gaps in BRSR P6 environmental disclosures and potential SEBI enforcement action or delisting risk under BRSR Core Expansion mandates. The company's medium GHG and water intensity risks (5.0/10 each) across a ₹1,437 crore revenue base create hidden operational leverage—if current unmeasured Scope 1/2 emissions total 50,000–150,000 tCO2e (typical for specialty chemical manufacturers), carbon pricing under India's upcoming CCTS could add ₹3–13.5 crore in future liabilities. Extended Producer Responsibility (EPR) exposure remains unquantified ("unknown" status), creating contingent cost risk for pharmaceutical and chemical product waste streams. Priority action: immediate completion of GHG accounting and BRSR P6 disclosure to mitigate regulatory penalties and clar

Source: Anupam Rasayan India Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.

← Back to ESG Quotient Dashboard Share on LinkedIn Browse all companies →